<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346912</article-id>
      <article-id pub-id-type="pmc">3875967</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132680</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pyoderma gangrenosum: skin grafting and hyperbaric oxygen as adjuvants in
the treatment of a deep and extensive ulcer<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Pioderma gangrenoso: enxerto de pele e oxigenoterapia hiperb&#xE1;rica como
adjuvantes no tratamento de &#xFA;lcera extensa e profunda</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#xFA;jo</surname>
            <given-names>Fernanda Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kondo</surname>
            <given-names>Rog&#xE9;rio Nabor</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Minelli</surname>
            <given-names>Lorivaldo</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD, resident of Dermatology Service, State University of Londrina (UEL)
- Londrina, Paran&#xE1;, Brazil.</aff>
      <aff id="aff02"><label>2</label> MD, dermatologist, assistant professor of Dermatology Service, State
University of Londrina - Londrina, Paran&#xE1;, Brazil.</aff>
      <aff id="aff03"><label>3</label> MD, PhD, dermatologist, associate professor of Dermatology Service,
State University of Londrina - Londrina, Paran&#xE1;, Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Fernanda Mendes Ara&#xFA;jo, Universidade Estadual de
Londrina, Rodovia PR 445, km 170 - Campus Universit&#xE1;rio UEL, 86051-990 - Londrina -
PR, Brazil. E-mail: <email>fernandamendes@me.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>176</fpage>
      <lpage>178</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>4</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>5</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Pyoderma gangrenosum is a rare dermatosis of unknown etiology and variable clinical
presentation. The disease is challenging for the medical staff, from the frequent
diagnostic difficulties to the lack of scientific evidence with a good level to
support the management of extensive and refractory cases. Our patient is a 50
year-old man with an extensive and deep ulcer on the left leg, which exemplifies the
therapeutic difficulties inherent to the disease and who, fortunately, has progressed
with excellent result after association of hyperbaric oxygen therapy and skin
grafting to the immunosuppression therapy initially proposed.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Pioderma gangrenoso &#xE9; dermatose rara de etiologia n&#xE3;o completamente compreendida e
apresenta&#xE7;&#xE3;o cl&#xED;nica vari&#xE1;vel. A doen&#xE7;a apresenta muitos desafios &#xE0; equipe m&#xE9;dica,
desde a freq&#xFC;ente dificuldade diagn&#xF3;stica at&#xE9; a inexist&#xEA;ncia de evid&#xEA;ncias
cient&#xED;ficas com bom n&#xED;vel para condu&#xE7;&#xE3;o de casos extensos e refrat&#xE1;rios. Apresentamos
o caso de um paciente masculino, 50 anos, com &#xFA;lcera extensa e profunda em perna
esquerda, que exemplifica bem a dificuldade terap&#xEA;utica e que, felizmente, evoluiu
com excelente resultado ap&#xF3;s associa&#xE7;&#xE3;o de oxigenoterapia hiperb&#xE1;rica e enxertia de
pele ao tratamento imunossupressor inicialmente proposto.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Hyperbaric oxygenation</kwd>
        <kwd>Pyoderma gangrenosum</kwd>
        <kwd>Skin transplantation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Pyoderma gangrenosum (PG) is a non-infectious, neutrophilic dermatosis that affects the
skin and occasionally, the subcutaneous tissue. It was first described by Brocq in 1916
as geometric phagedenism; the term PG was introduced in 1930 by Brunsting <italic>et
al</italic>, in reference to the equivocated idea of an infectious
etiology.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>This is a rare disease, with a difficult diagnosis and oftentimes a challenging
treatment. As the histologic findings are unspecific, the diagnosis is essentially
clinic and made after the exclusion of other pathologies.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> Because this illness has an unpredictable behavior, and
few prognostic indicators, treatment must be tailored to the case severity, the
patient's health status and the presence of associated systemic diseases.<sup><xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>Hyperbaric oxygen therapy (HBO) is already well documented as an adjuvant therapy to PG,
promoting symptomatic relief and helping in the cicatrization process.<sup><xref ref-type="bibr" rid="r04">4</xref>-<xref ref-type="bibr" rid="r08">8</xref></sup>
The procedure consists in the inhalation of oxygen (O<sub>2</sub>) at a 100%
concentration, with the patient positioned inside a chamber with a pressure superior to
the atmospheric one.<sup><xref ref-type="bibr" rid="r05">5</xref></sup> This
environment, rich in O<sub>2</sub>, increases the amount of oxygen dissolved in the
plasma, stimulating inflammatory and proliferative events that are necessary for wound
cicatrization process.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Skin grafting in PG wounds, though well documented in the literature as an option in
selected cases,<sup><xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup> remains as a topic of discussion. On one hand, there is
the patient's lack of complete response to the available clinical treatments. On the
other hand, there is the risk of loosing control of an illness that still challenges
medical knowledge.</p>
      <p>We report one case that clearly exemplifies the therapeutic difficulties inherent to
this disease, and which evolved well after the association of several therapeutic
options.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A fifty year-old male presented with an erythemato-violaceous nodule on the anterior
part of the left leg, which evolved to an ulcer with local pain after a surgical
intervention. After three surgical debridements and progressive worsening of the ulcer,
he was referred to the emergency room of a tertiary hospital. Physical examination
showed a deep and extensive ulcer on the left leg, with exposure of muscular tissue and
areas of purulent secretion and necrosis; the borders were altered by the recent
surgical intervention (<xref ref-type="fig" rid="f01">Figure 1</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Pyoderma gangrenosum: extensive ulcer in the anteriormedial part of the left leg,
with muscular tissue exposure, and areas of necrosis and purulent secretion; wound
borders were altered by a recent surgical intervention</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0176-g01"/>
      </fig>
      <p>After the exclusion of vascular and infectious causes, and based on clinical and
histological findings, the diagnosis of pyoderma gangrenosum (PG) was established (<xref ref-type="fig" rid="f02">Figure 2</xref>). The patient responded well to the therapy
initially started: antibiotics for the secondary infection and immunosuppression with
corticosteroid in a dose equivalent to 1mg/kg/day prednisone. Considering the extension
of the lesion and the aggressive behavior of the disease, azathioprine was introduced
early on, 20 days after the start of the corticosteroid therapy, with the goal of
weaning from the corticosteroids in a medium time frame. Because of the wound extension,
HBO was introduced concomitantly, to help in the cicatrization process. Forty-five days
after treatment beginning, there was a prominent superficial neovascularization on the
ulcer (<xref ref-type="fig" rid="f03">Figure 3</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Pyoderma gangrenosum. Histology showing occluded vessel <bold>(A)</bold> and
necrosis adjacent to a granuloma <bold>(B)</bold> (HE, 100x). Detail of the
granuloma: showing multinuclear giant cell, histiocytes <bold>(C)</bold> and
neutrophilic abscedation <bold>(D)</bold>. (HE, 400x)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0176-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Pyoderma gangrenosum, 45 days after corticosteroid therapy, azathioprine and
hyperbaric oxygen therapy: granular tissue with superficial neovascularization and
partial re-epithelization</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0176-g03"/>
      </fig>
      <p>Corticosteroid therapy was maintained until significant improvement in the aspect of the
lesion was achieved, followed by a slow and gradual reduction of dosage after 40 days of
use, and complete suspension 90 days after the medication was introduced.</p>
      <p>Due to incomplete re-epithelization of the wound, and considering its large dimensions
and the presence of well-vascularized granular tissue, we opted, five months after the
starting of the treatment, for a partial autologous skin graft on the ulcer bed. The
graft was performed whilst the patient was still receiving azathioprine and HBO. There
was graft take and complete closure of the wound (<xref ref-type="fig" rid="f04">Figures
4</xref> and <xref ref-type="fig" rid="f05">5</xref>). The patient is still using
azathioprine, and in 10 months of follow-up did not have relapses or complications.</p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Pyoderma gangrenosum, autologous skin graft over the wound, showing good
vascularization</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0176-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Pyoderma gangrenosum: excellent final result after immunosuppression, hyperbaric
oxygen therapy and partial skin grafting</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0176-g05"/>
      </fig>
      <p>The final diagnosis of ulcerative PG without subjacent disease was established after
extensive complementary investigation, after excluding intestinal inflammatory diseases,
hematologic and rheumatologic illnesses and neoplasia.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In extensive cases, as reported here, the initial treatment is based on systemic
corticosteroid therapy, with an early introduction of immunosuppressive drugs
(cyclosporine, azathioprine, cyclophosphamide) or sulphones (dapsone).<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r10">10</xref></sup>
Treatment of associated diseases, when present, contributes to a better control o PG in
most of the cases.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>Our patient responded in a satisfactory manner to the treatment proposed initially, with
the interruption of the disease progression and a slow, although significant,
improvement of the aspect of the lesion. HBO was introduced with the goal of
accelerating the tissue regeneration process in the wound. This is a safe and effective
therapy, with few adverse events and of relatively low-cost, which justifies its use in
adjuvant treatment of ulcers that are refractory to conventional therapy.<sup><xref ref-type="bibr" rid="r04">4</xref></sup> This technique contributes to pain and
infection reduction and also to the acceleration of cure process, increasing capillary
angiogenesis.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup> The wound oxygenation also increases the collagen
production by the fibroblasts, thus offering support to the newly formed capillary
vessels.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> In the case reported,
we considered that there was a marked improvement of the wound after a total of 81 HBO
sessions. Although the same results could be achieved with only immunosuppression and
wound care, the benefits of HBO and the simplicity of its implementation justify its use
in extensive cases like the one described here.</p>
      <p>In general, surgical procedures should be avoided in patients with PG, due to the
potential risk of worsening any pre-existing lesions or triggering the appearance of new
ones after the cutaneous trauma. The pathergy phenomenon, present in 20-30% of the
cases, may be the cause of autologous skin graft rejection, both in the donating as well
as in the receiving areas.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> In the
case reported, we considered that the risk of a skin grafting was justifiable and we
chose to perform it after 5 months of diagnosis, maintaining the use of azathioprine and
HBO, thus guaranteeing a better surgical result. Once again, we did not know if the
patient would have evolved satisfactorily only with the previously instituted therapy.
There are no scientific evidences that may offer a clear guidance in such cases. The
decision in favor of skin grafting was made as a consensus between the dermatology and
plastic surgery teams, after taking in consideration the risks, benefits, the patient's
wishes and the possibility of a more effective and quick recovery. The excellent
surgical result was due in part to the angiogenesis promoted by HBO, which helped not
only the cicatrization process but also the good evolution and survival of the
graft.</p>
      <p>As with all diseases of difficult management therapeutic decisions must be customized,
taking into consideration the patient's clinical sta tus and the risk-benefit ratio of
potentially risky procedures.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work performed at the dermatology service at the North Paran&#xE1; Regional University
Hospital - Londrina State University (UEL) - Londrina- Paran&#xE1; (PR), Brazil</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brocq</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title xml:lang="fr">Nouvelle contribution a l'&#xE9;tude du phag&#xE9;d&#xE9;nisme
g&#xE9;om&#xE9;trique</article-title>
          <source>Ann Dermatol Syphiligr</source>
          <year>1916</year>
          <volume>6</volume>
          <fpage>1</fpage>
          <lpage>39</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brunsting</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Goeckerman</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>O'Leary</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Pyoderma gangrenosum: clinical and experimental observation in five
cases occuring in adults</article-title>
          <source>Arch Dermatol Syphilol</source>
          <year>1930</year>
          <volume>22</volume>
          <fpage>655</fpage>
          <lpage>680</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruocco</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sangiuliano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gravina</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nicoletti</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Pyoderma gangrenosum: an updated review</article-title>
          <source>J Eur Acad Dermatol Venereol</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>1008</fpage>
          <lpage>1017</lpage>
          <pub-id pub-id-type="pmid">19470075</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mazokopakis</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Kofteridis</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Pateromihelaki</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Vytiniotis</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Karastergiou</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Improvement of ulcerative pyoderma gangrenosum with hyperbaric oxygen
therapy</article-title>
          <source>Dermatol Ther</source>
          <year>2011</year>
          <volume>24</volume>
          <fpage>134</fpage>
          <lpage>136</lpage>
          <pub-id pub-id-type="pmid">21276167</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vieira</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma
gangrenosum</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>1193</fpage>
          <lpage>1196</lpage>
          <pub-id pub-id-type="pmid">22281912</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Landeen</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Pyoderma gangrenosum: skin grafting after preparation with hyperbaric
oxygen</article-title>
          <source>Plast Reconstr Surg</source>
          <year>1987</year>
          <volume>79</volume>
          <fpage>200</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="pmid">3543980</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tutrone</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Caglar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Pyoderma gangrenosum: dermatologic application of hyperbaric oxygen
therapy</article-title>
          <source>J Drugs Dermatol</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>1214</fpage>
          <lpage>1219</lpage>
          <pub-id pub-id-type="pmid">18189061</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Altunay</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kucukunal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sarikaya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tukenmez Demirci</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A favourable response to surgical intervention and hyperbaric oxygen
therapy in pyoderma gangrenosum</article-title>
          <source>Int Wound J</source>
          <year>2012</year>
          <volume>29</volume>
          <pub-id pub-id-type="doi">10.1111/j.1742-481X.2012.01102.x</pub-id>
          <comment>Epub ahead of print</comment>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duarte</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Nogueira</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lisboa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Pyoderma gangrenosum - clinical, laboratory and therapeutic
approaches. Review of 28 cases</article-title>
          <source>Dermatol Online J</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>3</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">19903431</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahronowitz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Harp</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shinkai</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Etiology and management of pyoderma gangrenosum: a comprehensive
review</article-title>
          <source>Am J Clin Dermatol</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>191</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="pmid">22356259</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
